Abstract:The current interest in amorphous forms of active pharmaceutical ingredients stems from their increasing use in enabling formulations for the delivery of poorly water-soluble compounds. Because amorphous drugs are metastable and have a tendency to revert to crystalline forms, their crystallization behavior is an important topic. This study reports the observation of concomitant polymorphs of vemurafenib following crystallization from the supercooled liquid, and their subsequent phase transformations. The crystallization behavior of amorphous vemurafenib was evaluated between the glass transition temperature and melting temperature. Six characteristic crystal morphologies were observed. Based on X-ray diffraction and Raman spectroscopic studies, these morphologies were associated with four polymorphic forms, designated alpha, beta, gamma and delta. The thermodynamic stability is alpha > beta > gamma or delta. Isothermal crystallization between 120 and 240 degrees C resulted in concomitant polymorphs with samples containing either 2 or 3 of the 4 polymorphs depending on the specific temperatures, with the alpha-form or beta-form typically dominating. Crystallization at even higher temperature yielded only the alpha-form. A monotropic relationship was inferred between the alpha- and beta-forms based on calorimetric data. beta-to-alpha, gamma-to-beta, and delta-to-beta phase transformations were observed using hot-stage polarized light microscopy, Raman microscopy, and powder X-ray diffraction. The discovery of three new concomitant polymorphs of vemurafenib following crystallization from the supercooled liquid of vemurafenib highlights the rich polymorphic landscape that can be accessed by evaluating crystallization in supercooled liquids, and underscores the complexity in evaluating the crystallization of amorphous drug forms.

Exploring Solid Form Landscape of Anticancer Drug Dimethylaminomicheliolide Fumarate: Crystal Structures Analysis, Phase Transformation Behavior, and Physicochemical Properties Characterization

A New Strategy to Design Isostructural Salts: the Case of the Antitumor Drug Dimethylaminomicheliolide

Control over Polymorph Formation of Polydatin in Binary Solvent System and Structural Characterization

Polymorph Transformation of Solid Drugs and Inhibiting Strategies

Structure, Spectroscopy, and Theoretical insights on Co-crystals of 2,4-Diamino-6-Methyl-1,3,5-Triazine Bis(4-Aminobenzoic acid) Monohydrate as a promising anti-cancer agent

An integrated approach combining experimental, informatics and energetic methods for solid form derisking of PF-06282999

Polymorphic Transformation of Drugs Induced by Glycopolymeric Vesicles Designed for Anticancer Therapy Probed by Solid-State NMR Spectroscopy

Polymer Selection for Amorphous Solid Dispersion of a New Drug Candidate by Investigation of Drug Polymer Molecular Interactions.

Novel 9-Methylanthracene Derivatives as p53 Activators for the Treatment of Glioblastoma Multiforme

Study of Crystal Structures, Properties, and Form Transformations among a Polymorph, Hydrates, and Solvates of Apatinib

Crystal Structure Determination of New Antimitotic Agent Bis( p -fluorobenzyl)trisulfide

Non-alkylator Anti-Glioblastoma Agents Induced Cell Cycle G2/M Arrest and Apoptosis:Design, in Silico Physicochemical and SAR Studies of 2-Aminoquinoline-3-carboxamides.

Polymorphs, co-crystal structure and pharmacodynamics study of MBRI-001, a deuterium-substituted plinabulin derivative as a tubulin polymerization inhibitor.

Vemurafenib: A Tetramorphic System Displaying Concomitant Crystallization from the Supercooled Liquid

Polymorphs and pharmacokinetics of an antipsychotic drug candidate

Characterization, crystal structure and stability analysis of dianhydrodulcitol polymorphs

Novel 4-Aryl-4H-chromene derivative displayed excellent in vivo anti-glioblastoma efficacy as the microtubule-targeting agent

Solid-State Characterization and Insight into Transformations and Stability of Apatinib Mesylate Solvates

The Relevance of Crystal Forms in the Pharmaceutical Field: Sword of Damocles or Innovation Tools?

Polymorphs and Hydrates of Apatinib Mesylate: Insight into the Crystal Structures, Properties, and Phase Transformations

Discovery and Optimization of N-Arylated Tetracyclic Dicarboximides That Target Primary Glioma Stem-like Cells